Last10K.com

Biolargo, Inc. (BLGO) SEC Filing 8-K Material Event for the period ending Tuesday, March 5, 2019

Biolargo, Inc.

CIK: 880242 Ticker: BLGO

View differences made from one to another to evaluate Biolargo, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Biolargo, Inc..

Continue

Assess how Biolargo, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Biolargo, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Biolargo, Inc. provided additional information to their SEC Filing as exhibits

Ticker: BLGO
CIK: 880242
Form Type: 8-K Corporate News
Accession Number: 0001437749-19-004481
Submitted to the SEC: Fri Mar 08 2019 5:14:06 PM EST
Accepted by the SEC: Fri Mar 08 2019
Period: Tuesday, March 5, 2019
Industry: Chemicals And Allied Products
Events:
  1. Financial Exhibit
  2. New Agreement
  3. New Financial Obligation

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/blgo/0001437749-19-004481.htm